{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:43:44Z","timestamp":1790685824841,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT","award":["2014M3C7A1046049, to J-WK"],"award-info":[{"award-number":["2014M3C7A1046049, to J-WK"]}]},{"name":"the National Research Foundation (NRF), funded by the Korean government (MSIT), Republic of Korea","award":["2020R1A2C2101276, to DKK"],"award-info":[{"award-number":["2020R1A2C2101276, to DKK"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Achieving remission following initial antidepressant therapy in patients with major depressive disorder (MDD) is an important clinical result. Making predictions based on genetic markers holds promise for improving the remission rate. However, genetic variants found in previous genetic studies do not provide robust evidence to aid pharmacogenetic decision-making in clinical settings. Thus, the objective of this study was to perform whole-genome sequencing (WGS) using genomic DNA to identify genetic variants associated with the treatment outcomes of selective serotonin reuptake inhibitors (SSRIs). We performed WGS on 100 patients with MDD who were treated with escitalopram (discovery set: 36 remitted and 64 non-remitted). The findings were applied to an additional 553 patients with MDD who were treated with SSRIs (replication set: 185 remitted and 368 non-remitted). A novel loss-of-function variant (rs3213755) in keratin-associated protein 1\u20131 (<jats:italic>KRTAP1-1<\/jats:italic>) was identified in this study<jats:italic>.<\/jats:italic> This rs3213755 variant was significantly associated with remission following antidepressant treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.0184, OR 3.09, 95% confidence interval [CI] 1.22\u20137.80 in the discovery set; <jats:italic>p<\/jats:italic>\u2009=\u20090.00269, OR 1.75, 95% CI 1.22\u20132.53 in the replication set). Moreover, the expression level of <jats:italic>KRTAP1-1<\/jats:italic> in surgically resected human temporal lobe samples was significantly associated with the rs3213755 genotype. WGS studies on a larger sample size in various ethnic groups are needed to investigate genetic markers useful in the pharmacogenetic prediction of remission following antidepressant treatment.<\/jats:p>","DOI":"10.1038\/s41598-021-83887-6","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T06:04:11Z","timestamp":1614233051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Whole-genome sequencing reveals KRTAP1-1 as a novel genetic variant associated with antidepressant treatment outcomes"],"prefix":"10.1038","volume":"11","author":[{"given":"Jong-Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Won","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojae","family":"Myung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeok-Jae","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Soo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongHo","family":"Yum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Lim","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doh Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"83887_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin, D. S. et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry 75, 336\u2013346. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4602 (2018).","journal-title":"JAMA Psychiatry"},{"key":"83887_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archgenpsychiatry.2011.2044","volume":"69","author":"RD Gibbons","year":"2012","unstructured":"Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M. & Mann, J. J. Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch. Gen. Psychiatry 69, 572\u2013579. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.2044 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"83887_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0706743716659417","volume":"61","author":"SH Kennedy","year":"2016","unstructured":"Kennedy, S. H. et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Can. J. Psychiatry 61, 540\u2013560. https:\/\/doi.org\/10.1177\/0706743716659417 (2016).","journal-title":"Can. J. Psychiatry"},{"key":"83887_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpsychires.2008.05.002","volume":"43","author":"JM Hennings","year":"2009","unstructured":"Hennings, J. M. et al. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients\u2014findings from the Munich Antidepressant Response Signature (MARS) project. J. Psychiatr. Res. 43, 215\u2013229. https:\/\/doi.org\/10.1016\/j.jpsychires.2008.05.002 (2009).","journal-title":"J. Psychiatr. Res."},{"key":"83887_CR5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/sj.npp.1301131","volume":"31","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1841\u20131853. https:\/\/doi.org\/10.1038\/sj.npp.1301131 (2006).","journal-title":"Neuropsychopharmacology"},{"key":"83887_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0006-3223(94)90642-4","volume":"36","author":"RL O'Reilly","year":"1994","unstructured":"O\u2019Reilly, R. L., Bogue, L. & Singh, S. M. Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol. Psychiatry 36, 467\u2013471. https:\/\/doi.org\/10.1016\/0006-3223(94)90642-4 (1994).","journal-title":"Biol. Psychiatry"},{"key":"83887_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0022-3956(98)00004-1","volume":"32","author":"L Franchini","year":"1998","unstructured":"Franchini, L., Serretti, A., Gasperini, M. & Smeraldi, E. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J. Psychiatr. Res. 32, 255\u2013259. https:\/\/doi.org\/10.1016\/S0022-3956(98)00004-1 (1998).","journal-title":"J. Psychiatr. Res."},{"key":"83887_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/YIC.0000000000000305","volume":"35","author":"C Fabbri","year":"2020","unstructured":"Fabbri, C., Montgomery, S., Lewis, C. M. & Serretti, A. Genetics and major depressive disorder: Clinical implications for disease risk, prognosis and treatment. Int. Clin. Psychopharmacol. 35, 233\u2013242. https:\/\/doi.org\/10.1097\/YIC.0000000000000305 (2020).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"83887_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.biopsych.2012.10.030","volume":"73","author":"KE Tansey","year":"2013","unstructured":"Tansey, K. E. et al. Contribution of common genetic variants to antidepressant response. Biol. Psychiatry 73, 679\u2013682. https:\/\/doi.org\/10.1016\/j.biopsych.2012.10.030 (2013).","journal-title":"Biol. Psychiatry"},{"key":"83887_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.biopsych.2009.08.029","volume":"67","author":"HA Garriock","year":"2010","unstructured":"Garriock, H. A. et al. A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 67, 133\u2013138. https:\/\/doi.org\/10.1016\/j.biopsych.2009.08.029 (2010).","journal-title":"Biol Psychiatry"},{"key":"83887_CR11","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/archgenpsychiatry.2009.95","volume":"66","author":"M Ising","year":"2009","unstructured":"Ising, M. et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch. Gen. Psychiatry 66, 966\u2013975. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2009.95 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"83887_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1176\/appi.ajp.2009.09070932","volume":"167","author":"R Uher","year":"2010","unstructured":"Uher, R. et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am. J. Psychiatry 167, 555\u2013564. https:\/\/doi.org\/10.1176\/appi.ajp.2009.09070932 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"83887_CR13","doi-asserted-by":"publisher","first-page":"e1001326","DOI":"10.1371\/journal.pmed.1001326","volume":"9","author":"KE Tansey","year":"2012","unstructured":"Tansey, K. E. et al. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: A genome-wide analysis of individual-level data and a meta-analysis. PLoS Med. 9, e1001326. https:\/\/doi.org\/10.1371\/journal.pmed.1001326 (2012).","journal-title":"PLoS Med."},{"key":"83887_CR14","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/tpj.2012.32","volume":"13","author":"Y Ji","year":"2013","unstructured":"Ji, Y. et al. Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: Genome-wide associations and functional genomics. Pharmacogenom. J. 13, 456\u2013463. https:\/\/doi.org\/10.1038\/tpj.2012.32 (2013).","journal-title":"Pharmacogenom. J."},{"key":"83887_CR15","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1038\/tp.2015.173","volume":"5","author":"W Myung","year":"2015","unstructured":"Myung, W. et al. A genome-wide association study of antidepressant response in Koreans. Transl. Psychiatry 5, e672. https:\/\/doi.org\/10.1038\/tp.2015.173 (2015).","journal-title":"Transl. Psychiatry"},{"key":"83887_CR16","doi-asserted-by":"publisher","first-page":"e937","DOI":"10.1038\/tp.2016.187","volume":"6","author":"JM Biernacka","year":"2016","unstructured":"Biernacka, J. M. et al. The International SSRI Pharmacogenomics Consortium (ISPC): A genome-wide association study of antidepressant treatment response. Transl. Psychiatry 6, e937. https:\/\/doi.org\/10.1038\/tp.2016.187 (2016).","journal-title":"Transl. Psychiatry"},{"key":"83887_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/s0168-9525(01)02410-6","volume":"17","author":"DE Reich","year":"2001","unstructured":"Reich, D. E. & Lander, E. S. On the allelic spectrum of human disease. Trends Genet. 17, 502\u2013510. https:\/\/doi.org\/10.1016\/s0168-9525(01)02410-6 (2001).","journal-title":"Trends Genet."},{"key":"83887_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2013.09.006","volume":"155","author":"DC Koboldt","year":"2013","unstructured":"Koboldt, D. C., Steinberg, K. M., Larson, D. E., Wilson, R. K. & Mardis, E. R. The next-generation sequencing revolution and its impact on genomics. Cell 155, 27\u201338. https:\/\/doi.org\/10.1016\/j.cell.2013.09.006 (2013).","journal-title":"Cell"},{"key":"83887_CR19","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1038\/s41598-017-06522-3","volume":"7","author":"D Tombacz","year":"2017","unstructured":"Tombacz, D. et al. High-coverage whole-exome sequencing identifies candidate genes for suicide in victims with major depressive disorder. Sci. Rep. 7, 7106. https:\/\/doi.org\/10.1038\/s41598-017-06522-3 (2017).","journal-title":"Sci. Rep."},{"key":"83887_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","volume":"45","author":"X Zhang","year":"2005","unstructured":"Zhang, X. et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11\u201316. https:\/\/doi.org\/10.1016\/j.neuron.2004.12.014 (2005).","journal-title":"Neuron"},{"key":"83887_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/tpj.2016.77","volume":"18","author":"GEB Wright","year":"2018","unstructured":"Wright, G. E. B., Carleton, B., Hayden, M. R. & Ross, C. J. D. The global spectrum of protein-coding pharmacogenomic diversity. Pharmacogenom. J. 18, 187\u2013195. https:\/\/doi.org\/10.1038\/tpj.2016.77 (2018).","journal-title":"Pharmacogenom. J."},{"key":"83887_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/0269881113499829","volume":"27","author":"A Tammiste","year":"2013","unstructured":"Tammiste, A. et al. Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression. J. Psychopharmacol. 27, 915\u2013920. https:\/\/doi.org\/10.1177\/0269881113499829 (2013).","journal-title":"J. Psychopharmacol."},{"key":"83887_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144884","author":"HJ Kang","year":"2020","unstructured":"Kang, H. J. et al. Genetic markers for later remission in response to early improvement of antidepressants. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21144884 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"83887_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41398-020-0689-x","volume":"10","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder. Transl. Psychiatry 10, 30. https:\/\/doi.org\/10.1038\/s41398-020-0689-x (2020).","journal-title":"Transl. Psychiatry"},{"key":"83887_CR25","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41593-017-0017-9","volume":"20","author":"SJ Sanders","year":"2017","unstructured":"Sanders, S. J. et al. Whole genome sequencing in psychiatric disorders: The WGSPD consortium. Nat. Neurosci. 20, 1661\u20131668. https:\/\/doi.org\/10.1038\/s41593-017-0017-9 (2017).","journal-title":"Nat. Neurosci."},{"key":"83887_CR26","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498. https:\/\/doi.org\/10.1038\/ng.806 (2011).","journal-title":"Nat. Genet."},{"key":"83887_CR27","doi-asserted-by":"publisher","first-page":"e107098","DOI":"10.1371\/journal.pone.0107098","volume":"9","author":"SW Lim","year":"2014","unstructured":"Lim, S. W. et al. Genetic prediction of antidepressant drug response and nonresponse in Korean patients. PLoS\u00a0One 9, e107098. https:\/\/doi.org\/10.1371\/journal.pone.0107098 (2014).","journal-title":"PLoS\u00a0One"},{"key":"83887_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1176\/appi.ajp.2012.12020237","volume":"170","author":"GENDEP Investigators","year":"2013","unstructured":"GENDEP Investigators, MARS Investigators & STAR*D Investigators. Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies. Am. J. Psychiatry 170, 207\u2013217. https:\/\/doi.org\/10.1176\/appi.ajp.2012.12020237 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"83887_CR29","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41598-017-01617-3","volume":"7","author":"C Everaert","year":"2017","unstructured":"Everaert, C. et al. Benchmarking of RNA-sequencing analysis workflows using whole-transcriptome RT-qPCR expression data. Sci. Rep. 7, 1559. https:\/\/doi.org\/10.1038\/s41598-017-01617-3 (2017).","journal-title":"Sci. Rep."},{"key":"83887_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41375-018-0321-8","volume":"33","author":"JH Park","year":"2019","unstructured":"Park, J. H. et al. HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia. Leukemia 33, 1439\u20131450. https:\/\/doi.org\/10.1038\/s41375-018-0321-8 (2019).","journal-title":"Leukemia"},{"key":"83887_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0002-9440(10)65621-0","volume":"153","author":"VA Botchkarev","year":"1998","unstructured":"Botchkarev, V. A. et al. A new role for neurotrophin-3: Involvement in the regulation of hair follicle regression (catagen). Am. J. Pathol. 153, 785\u2013799. https:\/\/doi.org\/10.1016\/S0002-9440(10)65621-0 (1998).","journal-title":"Am. J. Pathol."},{"key":"83887_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/lm.76006","volume":"13","author":"K Shimazu","year":"2006","unstructured":"Shimazu, K. et al. NT-3 facilitates hippocampal plasticity and learning and memory by regulating neurogenesis. Learn. Mem. 13, 307\u2013315. https:\/\/doi.org\/10.1101\/lm.76006 (2006).","journal-title":"Learn. Mem."},{"key":"83887_CR33","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1080\/00207450802174589","volume":"118","author":"CU Pae","year":"2008","unstructured":"Pae, C. U., Marks, D. M., Han, C., Patkar, A. A. & Steffens, D. Does neurotropin-3 have a therapeutic implication in major depression?. Int. J. Neurosci. 118, 1515\u20131522. https:\/\/doi.org\/10.1080\/00207450802174589 (2008).","journal-title":"Int. J. Neurosci."},{"key":"83887_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.eurpsy.2017.06.009","volume":"46","author":"A Sheldrick","year":"2017","unstructured":"Sheldrick, A., Camara, S., Ilieva, M., Riederer, P. & Michel, T. M. Brain-derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3) levels in post-mortem brain tissue from patients with depression compared to healthy individuals - a proof of concept study. Eur. Psychiatry 46, 65\u201371. https:\/\/doi.org\/10.1016\/j.eurpsy.2017.06.009 (2017).","journal-title":"Eur. Psychiatry"},{"key":"83887_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443. https:\/\/doi.org\/10.1038\/s41586-020-2308-7 (2020).","journal-title":"Nature"},{"key":"83887_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/YIC.0b013e3283277614","volume":"24","author":"MH Trivedi","year":"2009","unstructured":"Trivedi, M. H. et al. Remission, response without remission, and nonresponse in major depressive disorder: Impact on functioning. Int. Clin. Psychopharmacol. 24, 133\u2013138. https:\/\/doi.org\/10.1097\/YIC.0b013e3283277614 (2009).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"83887_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrg1521","volume":"6","author":"JN Hirschhorn","year":"2005","unstructured":"Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95\u2013108. https:\/\/doi.org\/10.1038\/nrg1521 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"83887_CR38","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nrg2867","volume":"11","author":"V Bansal","year":"2010","unstructured":"Bansal, V., Libiger, O., Torkamani, A. & Schork, N. J. Statistical analysis strategies for association studies involving rare variants. Nat. Rev. Genet. 11, 773\u2013785. https:\/\/doi.org\/10.1038\/nrg2867 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"83887_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12920-019-0542-3","volume":"12","author":"BS Glicksberg","year":"2019","unstructured":"Glicksberg, B. S. et al. Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits. BMC Med. Genom. 12, 108. https:\/\/doi.org\/10.1186\/s12920-019-0542-3 (2019).","journal-title":"BMC Med. Genom."},{"key":"83887_CR40","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1001\/jama.296.13.1609","volume":"296","author":"H Kim","year":"2006","unstructured":"Kim, H. et al. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 296, 1609\u20131618. https:\/\/doi.org\/10.1001\/jama.296.13.1609 (2006).","journal-title":"JAMA"},{"key":"83887_CR41","volume-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR\u00ae","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR\u00ae 4th edn. (American Psychiatric Association, New York, 2000).","edition":"4"},{"key":"83887_CR42","volume-title":"User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version","author":"RL Spitzer","year":"1997","unstructured":"Spitzer, R. L., Gibbon, M. & Williams, J. B. User\u2019s Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version (American Psychiatric Publication, New York, 1997)."},{"key":"83887_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6, 278\u2013296. https:\/\/doi.org\/10.1111\/j.2044-8260.1967.tb00530.x (1967).","journal-title":"Br. J. Soc. Clin. Psychol."},{"key":"83887_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde, O., Ahlfors, U. G., Bech, P., Dencker, S. J. & Elgen, K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl. 334, 1\u2013100. https:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb10566.x (1987).","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"83887_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/mp.2008.116","volume":"15","author":"M Kato","year":"2010","unstructured":"Kato, M. & Serretti, A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry 15, 473\u2013500. https:\/\/doi.org\/10.1038\/mp.2008.116 (2010).","journal-title":"Mol. Psychiatry"},{"key":"83887_CR46","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1001\/jama.289.23.3152","volume":"289","author":"MB Keller","year":"2003","unstructured":"Keller, M. B. Past, present, and future directions for defining optimal treatment outcome in depression: Remission and beyond. JAMA 289, 3152\u20133160. https:\/\/doi.org\/10.1001\/jama.289.23.3152 (2003).","journal-title":"JAMA"},{"key":"83887_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2006.08.012","volume":"1118","author":"MJ Choi","year":"2006","unstructured":"Choi, M. J., Kang, R. H., Lim, S. W., Oh, K. S. & Lee, M. S. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res. 1118, 176\u2013182. https:\/\/doi.org\/10.1016\/j.brainres.2006.08.012 (2006).","journal-title":"Brain Res."},{"key":"83887_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000341876","volume":"66","author":"ES Won","year":"2012","unstructured":"Won, E. S., Chang, H. S., Lee, H. Y., Ham, B. J. & Lee, M. S. Association between serotonin transporter-linked polymorphic region and Escitalopram antidepressant treatment response in Korean patients with major depressive disorder. Neuropsychobiology 66, 221\u2013229. https:\/\/doi.org\/10.1159\/000341876 (2012).","journal-title":"Neuropsychobiology"},{"key":"83887_CR49","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324 (2009).","journal-title":"Bioinformatics"},{"key":"83887_CR50","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303. https:\/\/doi.org\/10.1101\/gr.107524.110 (2010).","journal-title":"Genome Res."},{"key":"83887_CR51","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164. https:\/\/doi.org\/10.1093\/nar\/gkq603 (2010).","journal-title":"Nucleic Acids Res."},{"key":"83887_CR52","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. Bioinformatics 26, 2069\u20132070. https:\/\/doi.org\/10.1093\/bioinformatics\/btq330 (2010).","journal-title":"Bioinformatics"},{"key":"83887_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326. https:\/\/doi.org\/10.1038\/nbt.1754 (2011).","journal-title":"Nat. Biotechnol."},{"key":"83887_CR54","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38, W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537 (2010).","journal-title":"Nucleic Acids Res."},{"key":"83887_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience 4, 7. https:\/\/doi.org\/10.1186\/s13742-015-0047-8 (2015).","journal-title":"Gigascience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83887-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83887-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T23:08:22Z","timestamp":1670022502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83887-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83887"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83887-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4552"}}